222 related articles for article (PubMed ID: 20126619)
1. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
[TBL] [Abstract][Full Text] [Related]
2. Nucleo-cytoplasmic localization domains regulate Krüppel-like factor 6 (KLF6) protein stability and tumor suppressor function.
Rodríguez E; Aburjania N; Priedigkeit NM; DiFeo A; Martignetti JA
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844588
[TBL] [Abstract][Full Text] [Related]
3. Krüppel-like factor 6 expression changes during trophoblast syncytialization and transactivates ßhCG and PSG placental genes.
Racca AC; Camolotto SA; Ridano ME; Bocco JL; Genti-Raimondi S; Panzetta-Dutari GM
PLoS One; 2011; 6(7):e22438. PubMed ID: 21799854
[TBL] [Abstract][Full Text] [Related]
4. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.
Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA
J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922
[TBL] [Abstract][Full Text] [Related]
5. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival.
Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G
Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of krUppel-like factor 6 protein in colorectal cancers.
Cho YG; Choi BJ; Song JW; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
World J Gastroenterol; 2006 Apr; 12(14):2250-3. PubMed ID: 16610031
[TBL] [Abstract][Full Text] [Related]
7. KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.
Teixeira MS; Camacho-Vanegas O; Fernandez Y; Narla G; DiFeo A; Lee B; Kalir T; Friedman SL; Schlecht NF; Genden EM; Urken M; Brandwein-Gensler M; Martignetti JA
Int J Cancer; 2007 Nov; 121(9):1976-1983. PubMed ID: 17621627
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer.
Pandya AY; Talley LI; Frost AR; Fitzgerald TJ; Trivedi V; Chakravarthy M; Chhieng DC; Grizzle WE; Engler JA; Krontiras H; Bland KI; LoBuglio AF; Lobo-Ruppert SM; Ruppert JM
Clin Cancer Res; 2004 Apr; 10(8):2709-19. PubMed ID: 15102675
[TBL] [Abstract][Full Text] [Related]
9. KLF6 Gene and early melanoma development in a collagen I-rich extracellular environment.
Huh SJ; Chen YL; Friedman SL; Liao J; Huang HJ; Cavenee WK; Robertson GP
J Natl Cancer Inst; 2010 Aug; 102(15):1131-47. PubMed ID: 20660366
[TBL] [Abstract][Full Text] [Related]
10. A new role for the Kruppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function.
Slavin DA; Koritschoner NP; Prieto CC; López-Díaz FJ; Chatton B; Bocco JL
Oncogene; 2004 Oct; 23(50):8196-205. PubMed ID: 15378003
[TBL] [Abstract][Full Text] [Related]
11. Krüppel-like factor 5 as potential molecular marker in cervical cancer and the KLF family profile expression.
Marrero-Rodríguez D; Taniguchi-Ponciano K; Jimenez-Vega F; Romero-Morelos P; Mendoza-Rodríguez M; Mantilla A; Rodriguez-Esquivel M; Hernandez D; Hernandez A; Gomez-Gutierrez G; Muñoz-Hernandez N; la Cruz HA; Vargas-Requena C; Díaz-Hernández C; Serna-Reyna L; Meraz-Rios M; Bandala C; Ortiz-Leon J; Salcedo M
Tumour Biol; 2014 Nov; 35(11):11399-407. PubMed ID: 25119587
[TBL] [Abstract][Full Text] [Related]
12. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
Park SS; Kim SW
Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
[TBL] [Abstract][Full Text] [Related]
13. Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer.
Ozdemir F; Koksal M; Ozmen V; Aydin I; Buyru N
Tumour Biol; 2014 Jun; 35(6):5219-25. PubMed ID: 24519062
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
15. Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.
Hartel M; Narla G; Wente MN; Giese NA; Martignoni ME; Martignetti JA; Friess H; Friedman SL
Eur J Cancer; 2008 Sep; 44(13):1895-903. PubMed ID: 18691883
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study on the expression of c-erbB2 oncoprotein in breast tumors].
Zhang Z; Xu G; Liu S
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):287-9. PubMed ID: 11038761
[TBL] [Abstract][Full Text] [Related]
17. KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway.
Liu J; Du T; Yuan Y; He Y; Tan Z; Liu Z
Mol Cell Biochem; 2010 Feb; 335(1-2):29-35. PubMed ID: 19707857
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MDM2 oncoprotein correlates with possession of estrogen receptor alpha and lack of MDM2 mRNA splice variants in human breast cancer.
Hori M; Shimazaki J; Inagawa S; Itabashi M; Hori M
Breast Cancer Res Treat; 2002 Jan; 71(1):77-83. PubMed ID: 11859876
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic significance of Krüppel-like transcription factor 6 expression in 67 patients with cutaneous malignant melanoma in China.
Zhang N; Qiu LY; Yang F; Gao W; Ma WY; Zhang M
Pol J Pathol; 2021; 72(3):245-251. PubMed ID: 35048637
[TBL] [Abstract][Full Text] [Related]
20. Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
Kurozumi S; Alsaleem M; Monteiro CJ; Bhardwaj K; Joosten SEP; Fujii T; Shirabe K; Green AR; Ellis IO; Rakha EA; Mongan NP; Heery DM; Zwart W; Oesterreich S; Johnston SJ
Breast Cancer Res; 2020 Aug; 22(1):85. PubMed ID: 32782013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
